【Detonate the stock price! 】 5 Chinese pharmaceutical companies approved to imitate Merck's COVID-19 oral drug What is the impact? On January 21, the news that five Chinese pharmaceutical companies were allowed to produce and imitate Merck's new crown oral drugs for free triggered the stock prices of related individual stocks. Brilliant Pharma's 20CM up, Aidi Pharmaceutical rose more than 10%, Fosun Pharma rose 5.98%,and Hong Kong stock Via Bio rose more than 13%. (China Securities News)